Diabetology & Metabolic Syndrome (Aug 2023)

Antidepressants and type 2 diabetes: highways to knowns and unknowns

  • Nahi Sabih Alruwaili,
  • Hayder M. Al-Kuraishy,
  • Ali I. Al-Gareeb,
  • Ali K. Albuhadily,
  • Amany E. Ragab,
  • Ahmad Awad Alenazi,
  • Athanasios Alexiou,
  • Marios Papadakis,
  • Gaber El-Saber Batiha

DOI
https://doi.org/10.1186/s13098-023-01149-z
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Type 2 diabetes (T2D) is a metabolic disease caused by the development of insulin resistance (IR), relative insulin deficiency, and hyperglycemia. Hyperglycemia-induced neurochemical dysregulation activates the progression of depression in T2D patients. Therefore, management of depression by antidepressant agents improves glucose homeostasis and insulin sensitivity. However, prolong use of antidepressant drugs may increase the risk for the development of T2D. However, there is strong controversy concerning the use of antidepressant drugs in T2D. Therefore, this review try to elucidate the potential effects of antidepressant drugs in T2D regarding their detrimental and beneficial effects.

Keywords